Czech Republic
Tuberculosis profile
Population  2012 11 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.037 (0.037–0.037) 0.35 (0.35–0.35)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0 (0–0)
Prevalence  (includes HIV+TB) 0.77 (0.31–1.4) 7.2 (2.9–13)
Incidence  (includes HIV+TB) 0.57 (0.5–0.64) 5.3 (4.7–6)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.01 (0.01–0.01)
Case detection, all forms (%) 99 (88–110)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 208 (37) Relapse 0 (0)
Smear-negative 268 (47) Treatment after failure 0 (0)
Smear-unknown / not done 0 (0) Treatment after default 0 (0)
Extrapulmonary 89 (16) Other 40 (100)
Other 0 (0)      
Total new 565   Total retreatment 40  
           
Other (history unknown) 0        
Total new and relapse 565   Total cases notified 605  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.5 1.7 1.4
Age < 15 1 3 1
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 69   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 72  
Retreatment 75  
TB/HIV 2012 Number (%)
TB patients with known HIV status 136 (22)
HIV-positive TB patients 6 (4)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.5 (0.56–3.3) 6.3 (0.16–30)
MDR-TB cases among notified pulmonary
TB cases
7 (3–16) 3 (0–12)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 371 (93%) 26 (65%) 397
Laboratory-confirmed MDR-TB cases 2 2 4
Patients started on MDR-TB treatment     4
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-24 Data: www.who.int/tb/data